This document is an excerpt from the EUR-Lex website
Document 22012D0159
Decision of the EEA Joint Committee No 159/2012 of 28 September 2012 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
Decision of the EEA Joint Committee No 159/2012 of 28 September 2012 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
Decision of the EEA Joint Committee No 159/2012 of 28 September 2012 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
OJ L 341, 13.12.2012, p. 9–10
(BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV) This document has been published in a special edition(s)
(HR)
In force
13.12.2012 |
EN |
Official Journal of the European Union |
L 341/9 |
DECISION OF THE EEA JOINT COMMITTEE
No 159/2012
of 28 September 2012
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area, as amended by the Protocol adjusting the Agreement on the European Economic Area, hereinafter referred to as ‘the Agreement’, and in particular Article 98 thereof,
Whereas:
(1) |
Annex II to the Agreement was amended by Decision of the EEA Joint Committee No 146/2012 of 13 July 2012 (1). |
(2) |
Commission Implementing Regulation (EU) No 84/2012 of 1 February 2012 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance phenoxymethylpenicillin (2) is to be incorporated into the Agreement. |
(3) |
Commission Implementing Regulation (EU) No 85/2012 of 1 February 2012 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance altrenogest (3) is to be incorporated into the Agreement. |
(4) |
Commission Implementing Regulation (EU) No 86/2012 of 1 February 2012 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance lasalocid (4) is to be incorporated into the Agreement. |
(5) |
Commission Implementing Regulation (EU) No 107/2012 of 8 February 2012 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance octenidine dihydrochloride (5) is to be incorporated into the Agreement. |
(6) |
Commission Implementing Regulation (EU) No 122/2012 of 13 February 2012 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance methylprednisolone (6) is to be incorporated into the Agreement. |
(7) |
Commission Implementing Regulation (EU) No 123/2012 of 13 February 2012 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance monepantel (7) is to be incorporated into the Agreement. |
(8) |
Commission Implementing Regulation (EU) No 201/2012 of 8 March 2012 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance nitroxinil (8) is to be incorporated into the Agreement. |
(9) |
Commission Implementing Regulation (EU) No 202/2012 of 8 March 2012 amending the Annex to Regulation (EU) No 37/2010 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin, as regards the substance pegylated bovine granulocyte colony stimulating factor (9) is to be incorporated into the Agreement, |
HAS ADOPTED THIS DECISION:
Article 1
The following indents shall be added in point 13 (Commission Regulation (EU) No 37/2010) of Chapter XIII of Annex II to the Agreement:
‘— |
32012 R 0084: Commission Implementing Regulation (EU) No 84/2012 of 1 February 2012 (OJ L 30, 2.2.2012, p. 1), |
— |
32012 R 0085: Commission Implementing Regulation (EU) No 85/2012 of 1 February 2012 (OJ L 30, 2.2.2012, p. 4), |
— |
32012 R 0086: Commission Implementing Regulation (EU) No 86/2012 of 1 February 2012 (OJ L 30, 2.2.2012, p. 6), |
— |
32012 R 0107: Commission Implementing Regulation (EU) No 107/2012 of 8 February 2012 (OJ L 36, 9.2.2012, p. 25), |
— |
32012 R 0122: Commission Implementing Regulation (EU) No 122/2012 of 13 February 2012 (OJ L 40, 14.2.2012, p. 2), |
— |
32012 R 0123: Commission Implementing Regulation (EU) No 123/2012 of 13 February 2012 (OJ L 40, 14.2.2012, p. 4), |
— |
32012 R 0201: Commission Implementing Regulation (EU) No 201/2012 of 8 March 2012 (OJ L 71, 9.3.2012, p. 37), |
— |
32012 R 0202: Commission Implementing Regulation (EU) No 202/2012 of 8 March 2012 (OJ L 71, 9.3.2012, p. 40).’. |
Article 2
The texts of Implementing Regulations (EU) No 84/2012, (EU) No 85/2012, (EU) No 86/2012, (EU) No 107/2012, (EU) No 122/2012, (EU) No 123/2012, (EU) No 201/2012 and (EU) No 202/2012 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 1 November 2012, provided that all the notifications under Article 103(1) of the Agreement have been made to the EEA Joint Committee (*1).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 28 September 2012.
For the EEA Joint Committee
The President
Atle LEIKVOLL
(1) OJ L 309, 8.11.2012, p. 31.
(*1) No constitutional requirements indicated.